Highlights and Quick Summary
- EPS (Basic) for the quarter ending March 31, 2023 was -0.16 (a -99.6% decrease compared to previous quarter)
- Year-over-year quarterly EPS (Basic) decreased by -74.19%
- Annual EPS (Basic) for 2022 was -2.23 (a -0.0% decrease from previous year)
- Annual EPS (Basic) for 2022 was -2.23 (a -99.65% decrease from previous year)
- Annual EPS (Basic) for 2021 was -646.0 (a 19900.0% increase from previous year)
- Twelve month EPS (Basic) ending March 31, 2023 was -41.25 (a -0.58% decrease compared to previous quarter)
- Twelve month trailing EPS (Basic) decreased by -65.52% year-over-year
Trailing EPS (Basic) for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| -41.25 | -41.49 | -119.48 | -119.63 |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Basic) of Benitec Biopharma Limited
Most recent EPS (Basic)of BNTC including historical data for past 10 years.Interactive Chart of EPS (Basic) of Benitec Biopharma Limited
Benitec Biopharma Limited EPS (Basic) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.16 | – | – | – | – |
| 2022 | -40.0 | -0.47 | -0.62 | -0.4 | -2.23 |
| 2021 | -117.99 | -0.62 | -60.0 | -164.69 | -646.0 |
| 2020 | – | -151.26 | -2.45 | -1.96 | -8.1 |
| 2019 | – | – | -2.0 | -1.34 | 3.45 |
| 2018 | – | – | – | – | -12.9 |
| 2017 | – | – | – | -3.3 | -7.35 |
| 2016 | 1.2 | – | – | – | -38.1 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology